Method for determining antibody dissociation rate
AssigneeAccess Medical Systems, Ltd.
InventorsRobert F. Zuk, Mohsen Karbaschi, Heng Wu, Haode Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeAccess Medical Systems, Ltd.
InventorsRobert F. Zuk, Mohsen Karbaschi, Heng Wu, Haode Chen
Estimating the term…
The present invention is directed to a method of measuring the dissociation rate of the binding of an antibody to an antigen. The method has two phases: a first phase of binding and a second phase of dissociation. The first phase of the assay has a probe coated with an antigen, or protein G, or an anti-human IgG Fc antibody. The probe is immersed in a sample solution containing an antibody, followed by a wash sequence, then the probe is transferred to a reagent with a biotinylated antigen. After an incubation, the antibody bound on the probe binds to the biotinylated antigen to form an immune complex. Fluorescent signal is produced by immersing the probe in a reagent having a fluorescent tagged streptavidin. The last step of the first phase is a measurement of fluorescent on the probe tip. The second phase of the assay is making subsequent fluorescent measurements over time to monitor the loss in fluorescence indicating dissociation of the immune complex and calculating the dissociation rate of the binding of the antibody to the antigen.
A method of measuring the dissociation rate of the binding of an antibody to an antigen, comprising the steps of:
A method of measuring the dissociation rate of the binding of an IgG antibody to an antigen of interest, comprising the steps of:
Dependencies are inferred from the claim text.